Answers are grounded in this paper and cite their sources.
In the face of global population aging, neurodegenerative diseases, particularly Alzheimer's disease (AD) and Parkinson's disease (PD), represent a challenge for modern medicine.These progressive and currently incurable conditions are characterized by the irreversible damage of neurons and myelin sheaths, ultimately resulting in profound impairment of motor and cognitive functions.Due to their long asymptomatic period, diagnosis is frequently made at a stage when substantial neuronal degeneration has already occurred.The pathogenesis of these disorders is multifactorial, with emerging evidence suggesting that vitamin D may contribute to their development and progression.Vitamin D plays a key role in the development and functioning of the central nervous system.It possesses neuroprotective properties and supports signaling and repair processes in neurons.Some observational studies report an association between vitamin D deficiency and an increased risk or greater severity of AD and PD, potentially through mechanisms involving impaired neuronal signaling, reduced synaptic plasticity, oxidative stress, and chronic neuroinflammation.However, these associations do not establish causality, and randomized clinical trials have not consistently demonstrated that vitamin D supplementation improves cognitive or motor outcomes, prevents disease development, or slows disease progression.These observations underscore the importance of further evaluating the potential role of vitamin D in neurodegenerative disorders and its implications for clinical management.The aim of this review was to evaluate the available evidence regarding the association between vitamin D deficiency and the development, progression, and severity of symptoms in AD and PD.
No takes yet. Share an insight, caveat, or question.
Kłosowicz et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: